Shengnuo Peptide Usa Inc - CA San Mateo, Menlo Park 94025

Shengnuo Peptide Usa Inc entered the industry of Commercial Biotechnical Research in 2013 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541711, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.

To acquire more information, please contact Elisa Yu by calling (650) 321-0168 during business hours. You can also write to the business’ Single Location at 1374 Willow Road, Menlo Park, California CA 94025. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Shengnuo Peptide Usa Inc
Representative: Elisa Yu
Place of Business: 1374 Willow Road, Menlo Park, CA 94025
Contact Number: (650) 321-0168
Type of Service: Commercial Biotechnical Research
SIC Number: 8731
NAICS Number: 541711
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2013
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Shengnuo Peptide Usa Inc is a company operating from San Mateo, California providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 2013 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 541711 as Commercial Biotechnical Research.

With a current employee count of 1 to 4, Shengnuo Peptide Usa Inc has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Elisa Yu at (650) 321-0168 for related queries, or to locate its Single Location using the coordinates 37.47817,-122.15148.

The Single Location can also be found at the street address 1374 Willow Road in Menlo Park, California 94025 and can be engaged online through the company website at , the company Twitter , and Facebook page .